View source for Lemon balm

{{PlantMedTemplate
| name         = Lemon balm
| binomial     = Melissa officinalis
| family       = Lamiaceae
| native_range = Southern Europe, western Asia, and northern Africa; naturalized through temperate Europe, the Americas, and Australasia. Wild populations occur on roadsides, hedgerows, disturbed ground, and the margins of woodland, particularly on calcareous soils. Widely cultivated as a garden and medicinal herb throughout the temperate world.
| plant_part   = Aerial parts (leaves and flowering tops), harvested just before full flowering when volatile oil content peaks; occasionally the essential oil distilled from fresh herb.
| image        =
| intro        = ''Melissa officinalis'' L. -- lemon balm, balm, melissa -- is a perennial herb of the mint family whose Greek name means bee, a record of the insects that congregate on its small white flowers and make from them a honey prized in antiquity. It has been called "the elixir of life" by Paracelsus and "sovereign for the brain" by John Evelyn; its unbroken reputation across two thousand years of Western and Islamic medicine is for lifting the heart, clearing the head, and settling the gut. The same compounds responsible for its sharp lemon scent -- the polyphenolic fraction concentrated in its leaves -- have turned out to be active against herpes simplex virus in controlled trials, giving it a specific antiviral credential unlike any other common nervine herb.

| history      = The genus name carries the oldest story. In Greek myth, Melissa was a bee-priestess of the mountain goddess Cybele; she fed the infant Zeus on honey when his father Kronos sought to devour him, and was afterward transformed into a bee. Theophrastus in the fourth century BCE noted that beekeepers rubbed hive entrances with melissa leaves to keep their colonies from straying -- a practice that survives in modern beekeeping -- and the plant's association with bees, honey, and the sweetness of life runs through every tradition that has known it.{{citation needed}}<!-- Candidate: Theophrastus. Enquiry into Plants. Standard English translation: Hort AF. Cambridge: Harvard University Press (Loeb Classical Library), 1916. Topic: Theophrastus on melissa and beekeeping. Also: Grieve M. A Modern Herbal. London: Jonathan Cape, 1931. No PMID; classical primary source. Verify chapter at publish. -->

Dioscorides, writing in the first century of the common era, described melissa as useful for treating scorpion stings, dog bites, and the spasms of nervous origin; he recorded it as an infusion for "those who suffer from melancholy," establishing the herb's neurological reputation at the foundational level of European botanical medicine.{{citation needed}}<!-- Candidate: Dioscorides P. De Materia Medica. Standard translation: Beck LY. Hildesheim: Olms-Weidmann, 2005. Topic: Dioscorides on melissa officinalis; indication for melancholy and nervous complaints. No PMID; classical primary source. Verify book and chapter at publish. --> The Romans cultivated it widely, and it passed from Roman gardens into the monastery.

Hildegard of Bingen in the twelfth century listed balm among the plants of the monastic garden that addressed the spiritual ailments she called melancholia; Paracelsus in the sixteenth century, temperamentally given to extreme claims, called it "the elixir of life" -- "among all the herbs none is better for the heart."{{citation needed}}<!-- Candidate: Paracelsus. Collected Works / Samtliche Werke. Sudhoff K, editor. Munich: Barth, 1922-1933. Also secondary source: Debus AG. The Chemical Philosophy: Paracelsian Science and Medicine in the Sixteenth and Seventeenth Centuries. New York: Science History Publications, 1977. Topic: Paracelsus on melissa as "elixir of life." No PMID; early modern primary and secondary sources. Verify quote at publish. --> John Gerard's Herball of 1597 recommended it for "driving away melancholly and heaviness of mind" and for "warming and comforting the heart."{{citation needed}}<!-- Candidate: Gerard J. The Herball, or Generall Historie of Plantes. London: John Norton, 1597. Topic: Gerard's entry on melissa; indications for melancholy. No PMID; early modern primary source. Verify at publish. -->

The most enduring and delightful preparation in lemon balm's history was not a medicine in the modern sense but a spirit: Carmelite water (eau des Carmes), developed by the Carmelite nuns in Paris in the fourteenth century from lemon balm, lemon peel, nutmeg, coriander, angelica root, and cloves in high-proof spirits. It circulated as a tonic for the heart, a remedy against fainting and melancholy, and a general cordial; Charles V of France was reputed to drink it daily.{{citation needed}}<!-- Candidate: social history of pharmacy or apothecary history text; no specific scholarly citation located. Topic: Carmelite water (eau des Carmes) origin, composition, 14th-century French Carmelite provenance, Charles V attribution. Q3 for home-claude: if a specific scholarly source can be located (Grieve, Rohde, or pharmacy history), insert it here. Otherwise carry {{citation needed}}. --> The preparation survives commercially today under the Boyer label in France, continuous from the 17th century, and may be the longest-lived packaged medicinal preparation in Western Europe.

John Evelyn, the English diarist and gardener, wrote in the late seventeenth century: "Balm is sovereign for the brain, strengthening the memory and powerfully chasing away melancholy."{{citation needed}}<!-- Candidate: Evelyn J. Acetaria: A Discourse of Sallets. London: B. Tooke, 1699. Topic: Evelyn on balm/melissa; quote attribution. No PMID; early modern primary source. Verify quote text and source publication at publish. --> The modern dimension was added not by herbalists but by laboratory pharmacologists. In 1994, the German physician and researcher Rainer Wölbling published the first rigorously controlled clinical trial of a standardized lemon balm cream -- subsequently commercialized as Lomaherpan -- applied to cold sores caused by herpes simplex virus.<ref name="wolbling1994">Wolbling RH, Leonhardt K. "Local therapy of herpes simplex with dried extract from ''Melissa officinalis''." Phytomedicine. 1994;1(1):25-31. PMID 23195812.</ref> The trial demonstrated that what herbalists had used empirically for mouth sores for centuries worked through a specific mechanism -- rosmarinic acid and other polyphenols blocking herpes virus attachment to host cells -- that remains among the most mechanistically coherent antiviral findings in phytomedicine.

| taxonomy     = ''Melissa officinalis'' L. is placed in tribe Mentheae, family Lamiaceae, the sole widely used species in the genus Melissa. The genus name derives from the Greek melissa (bee); the species epithet officinalis (of the dispensary) is shared with hundreds of medicinal plants and indicates long-standing apothecary use. No infraspecific taxa carry commercial or medicinal significance.

''L. officinalis'' is a vigorous, branching perennial growing to 1.5 m (5 ft), with deeply veined, toothed bright-green leaves that release a sharp lemon scent when crushed -- a quality immediately distinguishing it from mint (''Mentha'') and other Lamiaceae in the garden. The lemon scent derives principally from citronellal, a compound also responsible for the scent of lemongrass (''Cymbopogon citratus'') and lemon eucalyptus (''Corymbia citriodora''), reflecting convergent volatile chemistry across plant families rather than close botanical relationship.

The small white flowers, tinged pink or lilac, appear in dense axillary clusters from early summer onward; they are rich in nectar and unusually attractive to honeybees. In the garden lemon balm self-seeds freely and becomes naturalized with ease; it is one of the least demanding of the Lamiaceae in cultivation, tolerating partial shade, poor soils, and neglect.

The medicinal parts are the aerial parts -- leaves and flowering tops -- harvested just before full flowering when volatile oil content is highest. Post-flowering leaves are coarser in flavor and lower in volatile oil. The essential oil is produced commercially but is one of the most expensive in herbal commerce: approximately 3,000 to 5,000 kg of fresh leaf is required to produce 1 kg of oil, reflecting the low volatile oil yield (typically under 0.2 percent of fresh weight) and the labor-intensive harvest involved. The essential oil is rarely indicated in clinical practice and is used primarily in aromatherapy.

| traditional_uses = '''Western herbal medicine (primary centroid)'''

Lemon balm belongs to the nervine class of Western herbal medicine -- herbs with a primary action on the nervous system -- and is distinguished within that class by its particular gentleness: it is among the most pediatric-appropriate nervines in the Western tradition, given to colicky infants, anxious children, and restless adolescents alongside adults, without dose adjustment anxieties. This record of safe pediatric use across centuries is itself a kind of pharmacovigilance.

The principal traditional indications map closely onto the modern clinical evidence: anxiety and nervous agitation, insomnia with a restless or worried mind, palpitations from nervous origin (the "racing heart" that has no structural cardiac cause), nervous indigestion, colic and flatulence with an anxiety or tension component, and headache related to tension or nervous overload. The Carmelite water tradition adds a specifically cardiac tonifying dimension -- the heart-gladdening claim -- that aligns with both the nervous-palpitation indication and the mood-lifting effects documented in Kennedy's controlled trials two centuries later.

Secondary traditional indications include the antiviral use -- cold sores, oral herpes, used as topical fresh leaf or strong infusion -- which predates any knowledge of herpesvirus and reflects accurate empirical observation, and a diaphoretic use in febrile illness that made lemon balm standard in European childhood fever management.

'''Islamic medicine (Unani)'''

Lemon balm appears in Islamic-Galenic medicine as Turunjan (ترنجان) and, in some North African traditions, as Badharuj -- though this Arabic identifier is also applied by some sources to sweet basil (''Ocimum basilicum''), creating a minor source-identification ambiguity.{{citation needed}}<!-- Candidate: Morrow JA. Encyclopedia of Islamic Herbal Medicine. McFarland, 2011 (corpus: /home/claude/herbalist_corpus/books/john_morrow_encyclopedia_of_islamic_herbal_medicine). Topic: Turunjan / Badharuj identification with ''Melissa officinalis'' in Islamic medicine; ambiguity with ''Ocimum basilicum''. No PMID; secondary historical source. Verify at publish. --> Ibn Sina's Canon of Medicine praises it in terms that no other classical herbalist surpassed: lemon balm "causeth the heart and mind to become merry, exhilarateth the mind, settleth digestion, and is good against melancholy and the spleen." The Canon identifies it as a warming, drying herb good for cold temperaments, for cardiac palpitations, and for the "sadness and grief" that Ibn Sina associated with obstruction of the vital spirit.{{citation needed}}<!-- Candidate: Ibn Sina. Kitab al-Qanun fi al-Tibb (The Canon of Medicine). Standard English translation sections; or Gruner OC, translator. A Treatise on the Canon of Medicine of Avicenna. London: Luzac, 1930. Topic: Ibn Sina on Turunjan (lemon balm); cardiac, mood, and digestive indications. No PMID; medieval primary source. Verify at publish. -->

'''Ayurvedic medicine'''

Lemon balm is not a primary plant of the classical Ayurvedic pharmacopoeia -- its native range does not extend to the Indian subcontinent -- but it has been incorporated into contemporary Ayurvedic and integrative practice in Europe and North America where it overlaps with herbs of similar action. It is occasionally classified by contemporary Ayurvedic practitioners as a tridoshic nervine suitable for vata-type anxiety and pitta-type irritability.{{citation needed}}<!-- Candidate: contemporary Ayurvedic integrative herbal texts. Topic: Melissa in contemporary Ayurvedic practice; doshic classification. Carry {{citation needed}} if no specific primary Ayurvedic source locatable at publish. -->

| pharmacology = '''Volatile oil and polyphenolic constituents'''

The essential oil of ''M. officinalis'' is dominated by citral -- a mixture of the geometric isomers geranial and neral -- which accounts for the plant's characteristic lemon scent, along with citronellal, linalool, and caryophyllene oxide.{{citation needed}}<!-- Candidate: Charles DJ. Antioxidant Properties of Spices, Herbs and Other Sources. Springer, 2013; or Petersen M, Simmonds MS. "Rosmarinic acid." Phytochemistry. 2003;62(2):121-125. Topic: ''Melissa officinalis'' volatile oil composition; citral, citronellal, linalool percentages. Verify PMID or cite as monograph. --> The volatile oil fraction, however, is present in much lower concentration than in most other medicinal Lamiaceae (under 0.2 percent of fresh weight), and its contribution to the therapeutic actions of whole-plant preparations may be secondary to the non-volatile polyphenolic fraction.

Rosmarinic acid and related caffeic acid derivatives -- the principal polyphenolic compounds in lemon balm -- are the dominant pharmacologically active fraction for antiviral activity. Rosmarinic acid and the tannin fraction interfere with viral attachment to host cells by binding to glycoproteins on the herpes simplex virus (HSV) envelope, preventing the virus from docking with cell-surface receptors; this mechanism has been demonstrated in cell-culture models and correlates with the clinical efficacy of topical Melissa preparations in herpes labialis.{{citation needed}}<!-- Candidate: Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P. "Antiviral effect of aqueous extracts from species of the Lamiaceae family against ''Herpes simplex virus'' type 1 and type 2 in vitro." Planta Med. 2006. Or: Schnitzler P, Nolkemper S, Stintzing FC, Reichling J. Phytomedicine 2008. Topic: rosmarinic acid and Melissa polyphenols; anti-HSV mechanism, virion envelope glycoprotein binding, attachment inhibition. Verify PMID via eutils: "Melissa rosmarinic acid herpes simplex attachment." -->

The flavonoids (luteolin, apigenin) and triterpenes (ursolic and oleanolic acids) contribute anti-inflammatory and anxiolytic properties; apigenin in particular has affinity for the benzodiazepine receptor site of the GABA-A receptor, and this GABA-A interaction is the proposed basis for lemon balm's anxiolytic and mild sedative activity -- the same general mechanism as valerian, passionflower, and lavender, reflecting convergent pharmacology across unrelated plant families.{{citation needed}}<!-- Candidate: Viola H, Wasowski C, Levi de Stein M, et al. "Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects." Planta Med. 1995;61(3):213-216. PMID 7617761. Topic: apigenin as GABA-A benzodiazepine-site ligand; anxiolytic mechanism relevant to Melissa and other apigenin-rich herbs. Verify PMID. -->

The anti-thyroid mechanism is distinct from both of the above: aqueous extracts of ''Melissa officinalis'' inhibit binding of thyroid-stimulating hormone (TSH) and Graves' immunoglobulins to TSH receptors in vitro, reducing thyroid stimulation. The mechanism is thought to involve the polyphenolic fraction competitively occupying the TSH receptor or blocking immunoglobulin binding sites.

| clinical_evidence = '''Antiviral: herpes simplex (topical)'''

The strongest and most specific clinical evidence for lemon balm is topical and antiviral. The German physician Rainer Wölbling conducted the first placebo-controlled trial of a standardized Melissa cream on recurrent cold sores in 1994, demonstrating significant reduction in lesion size, healing time, and symptom severity with a 1 percent dried Melissa extract cream applied four times daily.<ref name="wolbling1994">Wolbling RH, Leonhardt K. "Local therapy of herpes simplex with dried extract from ''Melissa officinalis''." Phytomedicine. 1994;1(1):25-31. PMID 23195812.</ref>

Koytchev and colleagues (1999) confirmed and extended these findings in a larger placebo-controlled trial of the Lomaherpan-equivalent preparation (Lo-701, a 70:1 Melissa dry extract cream) applied four times daily to active cold sore lesions. The treated group showed significantly faster healing, smaller lesion area at day two, and reduced pain compared with placebo; the authors noted particularly strong benefit in patients treated at first symptom appearance (the prodrome or early vesicle stage) before full lesion development.<ref name="koytchev1999">Koytchev R, Alken RG, Dundarov S. "Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis." Phytomedicine. 1999;6(4):225-230. PMID 10589440.</ref>

The commercial preparation Lomaherpan (standardized 1 percent ''Melissa officinalis'' extract cream; Lomapharm, Germany) continues to be used and studied on this basis; it is the reference preparation for the EMA's traditional use opinion on Melissa for cold sores.

The evidence is specific to topical application: lemon balm polyphenols must be in direct contact with the HSV-infected tissue to exert their envelope-binding antiviral effect. Internal lemon balm preparations (infusion, tincture) have not been evaluated in placebo-controlled trials for recurrent herpes; the antiviral claim should not be extended to oral preparations without direct supporting evidence.

'''Mood and cognitive modulation (oral preparations)'''

Kennedy and colleagues conducted a series of dose-finding studies in healthy volunteers that provide the clearest pharmacological picture of oral lemon balm's cognitive and mood effects. In a 2002 crossover study, single doses of a standardized ''Melissa officinalis'' extract (300 mg, 600 mg, or 900 mg) produced dose-dependent improvements in calmness ratings and speed of mathematical processing on validated psychometric batteries; notably, the highest dose (900 mg) reduced calmness ratings relative to placebo, suggesting an inverted-U dose-effect relationship -- a feature consistent with the GABA-A modulation mechanism and commonly observed with GABAergic agents.<ref name="kennedy2002">Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA. "Modulation of mood and cognitive performance following acute administration of ''Melissa officinalis'' (lemon balm)." Pharmacology Biochemistry and Behavior. 2002;72(4):953-964. PMID 12062586.</ref>

A 2003 companion study found significant improvements in mood and cognitive performance following single oral doses, with dose-dependent effects on the speed of memory and spatial working memory tasks.<ref name="kennedy2003">Kennedy DO, Wake G, Savelev S, et al. "Modulation of mood and cognitive performance following acute administration of single doses of ''Melissa officinalis'' (lemon balm) with human pharmacological models." Neuropsychopharmacology. 2003;28(10):1871-1881. PMID 12888775.</ref>

In a 2006 study, Kennedy and colleagues evaluated a standardized combination of ''Melissa officinalis'' and ''Valeriana officinalis'' (valerian) extract under laboratory-induced stress conditions. The combination produced significant reductions in anxiety ratings during a multi-tasking battery, reductions in self-rated stress and alertness, and mood improvements relative to placebo; the effects were consistent with additive or synergistic action of the two plant extracts' respective mechanisms.<ref name="kennedy2006">Kennedy DO, Little W, Haskell CF, Scholey AB. "Anxiolytic effects of a combination of ''Melissa officinalis'' and ''Valeriana officinalis'' during laboratory induced stress." Phytotherapy Research. 2006;20(2):96-102. PMID 16444660.</ref>

These studies establish a real but modest anxiolytic and cognitive-modulating effect of oral lemon balm that is consistent with the GABA-A mechanism. Effect sizes are smaller than those seen with oral Silexan for generalized anxiety disorder; the evidence base is sufficient for mild-to-moderate situational anxiety but has not been evaluated against prescription anxiolytics in the manner of the Silexan trials.

'''Anti-thyroid activity (in vitro and limited clinical data)'''

Auf'mkolk and colleagues (1985) demonstrated in an in vitro receptor-binding assay that aqueous extracts of ''Melissa officinalis'' (and several other plants) inhibit the binding of thyroid-stimulating hormone and Graves' immunoglobulins to TSH receptors, reducing adenylate cyclase stimulation.<ref name="aufmkolk1985">Auf'mkolk M, Ingbar JC, Kubota K, Amir SM, Ingbar SH. "Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins." Endocrinology. 1985;116(5):1687-1693. PMID 2985357.</ref> This finding has been used as the pharmacological rationale for combining lemon balm with bugleweed (''Lycopus europaeus'') as an adjunctive herbal support in mild hyperthyroidism and Graves' disease; controlled clinical trials evaluating this combination for clinical outcomes in hyperthyroid patients are limited in number and quality.{{citation needed}}<!-- Candidate: Winterhoff H et al. on Lycopus and Melissa for hyperthyroidism; search "Lycopus Melissa hyperthyroidism clinical trial" on eutils. Topic: clinical evidence for lemon balm in hyperthyroidism; combination with bugleweed. Verify PMID at publish. -->

'''Pediatric use'''

The use of lemon balm for sleep disturbance and nervousness in children is supported by tradition, basic safety data, and a limited clinical literature that includes combination preparations (valerian plus lemon balm).{{citation needed}}<!-- Q2 for home-claude: locate PMID for combined valerian + lemon balm pediatric RCT (search "Melissa ''Valeriana'' children restlessness" or "lemon balm valerian children sleep randomized"). If found, insert ref. Otherwise carry {{citation needed}}. --> No serious adverse effects attributable to lemon balm have been reported in pediatric use at traditional doses.

| preparations = Infusion (tea): 2 to 4 g dried leaf and flowering tops per cup of hot water, covered while steeping (10 to 15 minutes) to retain the volatile oil fraction; the covering step is not cosmetic -- the volatile constituents are pharmacologically active and evaporate readily. Taken three times daily for daytime use or before sleep for insomnia.

Tincture: 1:5 in 45 percent ethanol from dried herb; standard liquid preparation for internal use; 2 to 6 ml per dose, three times daily.

Standardized dry extract: solid extract standardized to rosmarinic acid content (typically 3 to 5 percent), usually in capsule form; the preparation form used in the Kennedy cognitive-modulation studies (300 to 900 mg per dose).

Topical cream: 1 percent standardized Melissa dry extract (Lomaherpan; equivalent commercial preparations) applied topically to cold sore lesions at first symptom; the antiviral evidence is specific to topical preparations with defined rosmarinic acid content.

Essential oil: rarely used therapeutically; primarily aromatherapy; expensive and frequently adulterated with lemongrass (''Cymbopogon citratus'') or lemon-scented verbena (''Aloysia citrodora'') oil; if used, always diluted in carrier oil.

Combination preparations: Melissa plus ''Valeriana officinalis'' (valerian) is the most common commercial combination, targeting sleep and mild anxiety; this combination has the best clinical evidence base (Kennedy 2006) for lemon balm's anxiolytic and sleep-promoting effects.

| dosing = '''Internal preparations'''

Infusion: 2 to 4 g dried leaf per cup, three times daily and before bed. Acute use for nervous agitation or palpitations: a strong cup (double strength, 4 g covered, 15-minute steep) taken as needed.

Tincture (1:5 in 45 percent ethanol): 2 to 6 ml per dose, three times daily. Children: no established dose adjustment in traditional use; standard practice has been to reduce proportionally by body weight or to use a weaker preparation (diluted infusion), noting the absence of observed adverse effects in pediatric use at herbal practice doses.

Standardized extract: 300 to 600 mg per dose (consistent with Kennedy's effective dose range); 900 mg per dose has been associated with reduced calmness in Kennedy's studies and should be avoided as a starting dose.

For cold sore prevention with oral preparations: no clinical evidence base; oral lemon balm does not substitute for topical treatment and no internal anti-HSV dose has been evaluated.

Combination preparations (Melissa plus valerian): follow manufacturer dosing; typically one to two capsules or 5 to 10 ml liquid combination tincture at bedtime for sleep.

'''Recreational dose ladder'''

Lemon balm has no established recreational dose structure. Its sedative-anxiolytic effect at therapeutic doses is among the gentlest in the nervine class -- substantially milder than valerian, kava, or cannabis -- and dose escalation beyond the Kennedy effective range (300 to 600 mg standardized extract) produces diminishing benefit rather than progressive relaxation, as the 900 mg dose in Kennedy's studies reduced, rather than increased, calmness. No ethnobotanical or contemporary self-dosing literature documents recreational use of lemon balm in any form; the ceiling of effect at accessible doses is simply too low and too undramatic to attract recreational interest. No tiered dose ladder is warranted.

| pharmacokinetics = The pharmacokinetics of lemon balm's active constituents have not been characterized to the same degree as those of pharmaceutical preparations. Rosmarinic acid, the principal polyphenolic constituent, is absorbed from the gastrointestinal tract and undergoes conjugation and hydroxylation by intestinal microbiota and hepatic enzymes; plasma levels peak approximately 30 to 60 minutes after ingestion.{{citation needed}}<!-- Candidate: Baba S, Osakabe N, Natsume M, Terao J. "Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid." Life Sci. 2004. Topic: rosmarinic acid pharmacokinetics; plasma peak; metabolic pathway. Verify PMID via eutils "rosmarinic acid pharmacokinetics absorption plasma." --> The apigenin and luteolin flavonoids have been more extensively characterized in other botanical contexts and show oral bioavailability dependent on gut microbiome composition.

| interactions    = Central nervous system depressants: additive effect expected with sedatives, anxiolytics, alcohol, and sedating herbal medicines (valerian, hops, passionflower, kava); lemon balm's own sedative effect is mild, but the interaction is pharmacologically consistent and clinically relevant when adding lemon balm to a regimen that includes prescription sedatives or anxiolytics. Therapeutic use with benzodiazepines should be mentioned to the prescriber.

Thyroid preparations: theoretical antagonism with levothyroxine and other thyroid hormone replacement if lemon balm's anti-TSH-receptor activity translates to clinical reduction of thyroid function; this is relevant primarily at high chronic doses in patients with hypothyroidism or those on replacement thyroid therapy. At standard infusion doses, the interaction is theoretical rather than documented; in practice, standard tea use is unlikely to produce clinically significant thyroid antagonism.

| interactionsummary = Additive CNS sedation with sedatives and anxiolytics. Theoretical thyroid hormone antagonism at high doses in hypothyroid patients.

| safety          = Lemon balm has an outstanding safety record across two thousand years of use in children and adults. No serious adverse events have been reported in clinical trials, case reports, or systematic reviews at standard therapeutic doses. It is among the herbs most consistently identified as safe for children in the traditional and contemporary herbal literature.

Hypothyroidism: the anti-thyroid mechanism identified by Auf'mkolk (1985) in vitro has led to a theoretical caution for chronic high-dose oral use in patients with established hypothyroidism or those on thyroid hormone replacement. Standard infusion use (2 to 4 g dried herb three times daily) has not produced clinical hypothyroidism in case reports; the caution is precautionary at current doses. Patients with established hypothyroidism on levothyroxine who wish to use lemon balm chronically should have thyroid function monitored.

Pregnancy: lemon balm is used traditionally during pregnancy and lactation as a calming herb, and is one of the nervines most commonly recommended for perinatal anxiety in traditional midwifery practice. No clinical trial data in pregnancy exists. Consensus in contemporary herbal practice is that standard infusion doses are likely safe; concentrated extracts and high-dose standardized preparations have not been evaluated and should be used conservatively in pregnancy.

Allergic reactions to lemon balm are rare; contact dermatitis has been reported with the essential oil and less commonly with topical fresh plant preparations.

| monitoring      = No routine monitoring required for standard-dose internal use in healthy adults. Patients with hypothyroidism or on thyroid hormone replacement using chronic lemon balm preparations: thyroid-stimulating hormone at baseline and after two to three months of regular use. Patients adding lemon balm to benzodiazepine or sedative regimens: monitor for excess sedation, particularly at treatment initiation.

| counseling      = The distinction between oral and topical applications is important to convey clearly. Oral lemon balm (infusion, tincture, extract) is indicated for anxiety, nervous insomnia, palpitations, and nervous digestive symptoms; the clinical evidence for these indications is consistent but modest. Topical Lomaherpan-equivalent cream (1 percent standardized Melissa extract) is the form with the specific antiviral evidence for cold sores, applied at first sign of prodrome; oral lemon balm should not be presented as a substitute for the topical application in herpes management.

Patients with recurrent cold sores benefit most from topical treatment begun at prodrome (tingling, burning, or itching before vesicle formation) rather than after full blister development; early application is the message from Koytchev (1999) and consistent with the mechanism of attachment inhibition working best before viral invasion is complete.

Patients using lemon balm for anxiety who are not experiencing adequate response at standard infusion doses may benefit from a standardized extract at the 300 to 600 mg range, or from a Melissa plus valerian combination product (which has the best clinical evidence for the combined anxiolytic-sleep indication). If anxiety is more than mild to moderate, a clinical assessment for generalized anxiety disorder, for which Silexan (oral lavender oil) has substantially stronger evidence, is appropriate.

| regulatory      = '''Germany and European Union'''

German Commission E: lemon balm (Melissenblätter) approved for nervous sleep disorders and functional gastrointestinal complaints; covers dried herb preparations (infusion, tincture) based on traditional use and the clinical evidence base.

EMA HMPC: positive opinion for traditional use of ''Melissa officinalis'' leaf for relief of mild symptoms of stress and to aid sleep; also for traditional use of standardized topical preparations for symptomatic treatment of cold sores (Herpes labialis). One HMPC monograph (EMA/HMPC/196745/2012) covers both the internal nervine/sleep indication and the topical herpes simplex indication.<ref name="ema-hmpc-melissa">European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on ''Melissa officinalis'' L., folium. EMA/HMPC/196745/2012. First published: 5 August 2013. https://www.ema.europa.eu/en/medicines/herbal/melissae-folium.</ref>

'''United States'''

''Melissa officinalis'': GRAS (generally recognized as safe) as a food flavoring; sold as a dietary supplement under DSHEA without FDA evaluation of efficacy claims. No approved drug indication.

'''United Kingdom'''

MHRA traditional herbal registration: ''Melissa officinalis'' preparations registered for traditional use for mild anxiety and sleep disturbance, and for topical application to cold sores; the topical Lomaherpan-equivalent preparations are registered separately.

| history        =
| effects        =
| traditional_geography =
| anecdotes      =
}}

== References ==
<references/>

[[Category:Plants]]
[[Category:Herbal medicines]]
[[Category:Medicines]]
[[Category:Nervine herbs]]
[[Category:Anxiolytic herbs]]
[[Category:Digestive herbs]]
[[Category:Carminatives]]
[[Category:Western clinical herbs]]